Modelling the cost-effectiveness PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
Korman, Max, Wisløff, TorbjørnLanguage:
english
Journal:
European Heart Journal - Cardiovascular Pharmacotherapy
DOI:
10.1093/ehjcvp/pvx010
Date:
April, 2017
File:
PDF, 1.75 MB
english, 2017